The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 20, 2021
Filed:
May. 11, 2017
Applicants:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang, CN;
Medshine Discovery Inc., Nanjing, CN;
Inventors:
Haiying He, Nanjing, CN;
Songliang Wu, Nanjing, CN;
Zhi Luo, Nanjing, CN;
Jianfeng Mou, Nanjing, CN;
Fengying Guo, Nanjing, CN;
Chuan Wang, Nanjing, CN;
Guoqing Li, Nanjing, CN;
Minggao Zeng, Nanjing, CN;
Shuhui Chen, Nanjing, CN;
Assignees:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang, CN;
Medshine Discovery Inc., Nanjing, CN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 225/22 (2006.01); C07C 225/10 (2006.01); C07C 225/18 (2006.01); C07D 205/04 (2006.01); C07D 207/04 (2006.01); C07D 221/22 (2006.01); C07D 221/20 (2006.01); C07D 221/04 (2006.01); C07D 223/04 (2006.01); C07D 265/30 (2006.01); C07D 267/12 (2006.01); C07D 401/06 (2006.01); A61P 43/00 (2006.01); C07D 409/06 (2006.01); C07D 211/62 (2006.01); C07D 451/02 (2006.01); A61K 31/46 (2006.01); A61K 31/445 (2006.01); C07C 237/12 (2006.01); C07D 211/60 (2006.01); C07D 207/06 (2006.01); C07D 227/04 (2006.01); C07D 239/26 (2006.01); C07D 333/10 (2006.01); C07D 333/72 (2006.01); C07D 413/06 (2006.01);
U.S. Cl.
CPC ...
C07C 225/22 (2013.01); A61K 31/445 (2013.01); A61K 31/46 (2013.01); A61P 43/00 (2018.01); C07C 237/12 (2013.01); C07D 205/04 (2013.01); C07D 207/06 (2013.01); C07D 211/60 (2013.01); C07D 211/62 (2013.01); C07D 221/04 (2013.01); C07D 221/22 (2013.01); C07D 223/04 (2013.01); C07D 227/04 (2013.01); C07D 239/26 (2013.01); C07D 265/30 (2013.01); C07D 333/10 (2013.01); C07D 333/72 (2013.01); C07D 401/06 (2013.01); C07D 409/06 (2013.01); C07D 413/06 (2013.01); C07D 451/02 (2013.01);
Abstract
Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.